Clinical Trial Update: Treatment With Copper in Patients With Mild Alzheimer´s Dementia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating copper supplementation in patients with mild Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Copper supplementation (Copper)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Alzheimer´s Disease | Phase 2 | Status: COMPLETED